Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients
ConditionVentilated Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
The hypothesis of the present study is that restoring nasal stimulation alleviates dyspnea and improves respiratory drive. The aim of this study is to compare three non-pharmacological approaches designed to restore nasal stimulation (continuous nasal airflow, nasal sprays, and facial airflow) in tracheotomized patients dependent on mechanical ventilation.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Tracheostomy and mechanical ventilation
Dyspnea ≥3
Consent to participate
Disqualifiers
Agitation, delirium
Continuous use of sedatives
Patients under law protection
Inmates
Trial design
Treatments tested in this trial
- Baseline
- Installation of high flow humidified air cannula
- Nasal air puffs
- propeller fan (FAN)
Treatment groups
24 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov